180 Life Sciences Corp (ATNF)
2.68
-0.21
(-7.27%)
USD |
NASDAQ |
Nov 14, 16:00
2.69
+0.01
(+0.37%)
After-Hours: 07:43
180 Life Sciences Free Cash Flow (Quarterly): 0.7272M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.7272M |
March 31, 2024 | -1.033M |
December 31, 2023 | -2.16M |
September 30, 2023 | -1.776M |
June 30, 2023 | -3.117M |
March 31, 2023 | -3.870M |
December 31, 2022 | -2.927M |
September 30, 2022 | -3.596M |
June 30, 2022 | -3.532M |
Date | Value |
---|---|
March 31, 2022 | -2.073M |
December 31, 2021 | -5.028M |
September 30, 2021 | -4.003M |
June 30, 2021 | -4.011M |
March 31, 2021 | -6.33M |
December 31, 2020 | -3.216M |
September 30, 2020 | -0.054M |
June 30, 2020 | -0.1926M |
March 31, 2020 | -0.409M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-6.33M
Minimum
Mar 2021
0.7272M
Maximum
Jun 2024
-2.589M
Average
-3.022M
Median
Free Cash Flow (Quarterly) Benchmarks
Seelos Therapeutics Inc | -0.972M |
NovaBay Pharmaceuticals Inc | -2.063M |
Palatin Technologies Inc | -6.477M |
iBio Inc | -4.854M |
Theriva Biologics Inc | -3.453M |